RE: News10 Jun 2018 13:25
Thanks for posting that link C7 - I remember it when it came out, but it was good to read again. You earlier posed the question about what others think might come next - I wouldn't like to guess, and others have covered the possibilities on and off - however what did strike me when thinking back over the last few years is that not only has the horizon broadened for Scancell as their platforms have started to produce more and more potential products, but nothing has been abandoned or seen to fail. I know things have gone a lot slower than many would like, but that is imo more due to diligence than anything else. There is a tendency to overlook the highly significant and potentially pivotal nature of things like a strong link to Biontech, Roche, CRUK etc, but Scancell has them. Remember 'the doors are open and we are walking through them'? Well didn't they just! And presumably still are with others for all we know. But as I have said before, works of art take time. What's next? Well with the way the immunotherapy market has become such a hot area recently (validating RG and LD's sustained faith in their work) and the way SCIB and MODI are producing results, plus the collaborations with BioNtech, CRUK etc, (and add in the fact that the placing is out of the way and funds are very healthy for the good foreseeable) I am expecting only good news from here - preferably soon but I can wait. Stuff like the IND, possibly some reaction to the publishing of the patent, maybe some more news re patient advocacy groups, and fruits of the very significant collaborations with the best in the business - a fact nobody has ever denied or even tried to dispute. Then the Grand Challenge of course - no guarantee of a win, but if they do get an award then that is yet another major milestone in publicity and moving forward, once more with the leaders in the industry. Like I said, building block after building block. The bigger the house, the longer it takes to put in the foundations and connect the services, but I think things could well get very much more interesting in the second half of this year even if we don't get bigger news in the very near future.